furosemide has been researched along with Lung Diseases in 65 studies
Furosemide: A benzoic-sulfonamide-furan. It is a diuretic with fast onset and short duration that is used for EDEMA and chronic RENAL INSUFFICIENCY.
furosemide : A chlorobenzoic acid that is 4-chlorobenzoic acid substituted by a (furan-2-ylmethyl)amino and a sulfamoyl group at position 2 and 5 respectively. It is a diuretic used in the treatment of congestive heart failure.
Lung Diseases: Pathological processes involving any part of the LUNG.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To evaluate the efficacy of furosemide for prevention of exercise-induced pulmonary hemorrhage (EIPH) in Thoroughbred racehorses under typical racing conditions." | 9.14 | Efficacy of furosemide for prevention of exercise-induced pulmonary hemorrhage in Thoroughbred racehorses. ( Guthrie, AJ; Hinchcliff, KW; Morley, PS, 2009) |
| "A total of 95 patients seen in general practice with oedema associated with heart failure took part in an open study of the efficacy and tolerability of a combination tablet containing 40 mg frusemide and 5 mg amiloride." | 9.05 | Frusemide/amiloride combination ('Frumil') in heart failure: an open, multi-centre study in general practice. ( Eason, CT; Richards, HH; Townsend, HA; Waddy, AL, 1984) |
| "To assess urinary aldosterone excretion (UAE) and electrolytic balance in very low-birth weight (VLBW) infants who received chronic therapy with furosemide and to compare them with those of infants who did not receive diuretic therapy." | 7.77 | Urinary aldosterone excretion and electrolytic balance in response to chronic diuretic therapy in very low-birth weight infants. ( Costa, S; Cota, F; Gallini, F; Latella, C; Maggio, L; Romagnoli, C, 2011) |
| "The objective was to quantify the effect of furosemide and carbazochrome on exercise-induced pulmonary hemorrhage (EIPH) in Standardbred horses using red blood cell count and hemoglobin concentration in bronchoalveolar lavage (BAL) fluid." | 7.75 | Effect of furosemide and furosemide-carbazochrome combination on exercise-induced pulmonary hemorrhage in Standardbred racehorses. ( Couëtil, LL; Ochoa-Acuña, HG; Perez-Moreno, CI; Pratt, SM; Raskin, RE; Russell, MA, 2009) |
| "Of 61 horses with a history of exercise-induced pulmonary hemorrhage and treated with furosemide 4 hours prior to racing, 34 (55." | 7.67 | Exercise-induced pulmonary hemorrhage in thoroughbred horses: response to furosemide or hesperidin-citrus bioflavinoids. ( Soma, LR; Sweeney, CR, 1984) |
| "In 3 groups of horses with exercise-induced pulmonary hemorrhage (EIPH), comparisons of racing times and finishing positions were made between the 5 races before the horses were given furosemide and 5 races after furosemide administration." | 7.67 | Effects of furosemide on the racing times of horses with exercise-induced pulmonary hemorrhage. ( Barr-Alderfer, V; Laster, L; Oppenlander, F; Soma, LR, 1985) |
| "To evaluate the efficacy of furosemide for prevention of exercise-induced pulmonary hemorrhage (EIPH) in Thoroughbred racehorses under typical racing conditions." | 5.14 | Efficacy of furosemide for prevention of exercise-induced pulmonary hemorrhage in Thoroughbred racehorses. ( Guthrie, AJ; Hinchcliff, KW; Morley, PS, 2009) |
| "A total of 95 patients seen in general practice with oedema associated with heart failure took part in an open study of the efficacy and tolerability of a combination tablet containing 40 mg frusemide and 5 mg amiloride." | 5.05 | Frusemide/amiloride combination ('Frumil') in heart failure: an open, multi-centre study in general practice. ( Eason, CT; Richards, HH; Townsend, HA; Waddy, AL, 1984) |
| "Furosemide has been used empirically and has been legally approved for many years by the US racing industry for the control of exercise-induced pulmonary haemorrhage (EIPH) or bleeding." | 4.80 | Review of furosemide in horse racing: its effects and regulation. ( Soma, LR; Uboh, CE, 1998) |
| "Public pressure exists in the United States to eliminate race-day furosemide administration despite its efficacy in decreasing the severity of equine exercise pulmonary hemorrhage (EIPH)." | 3.91 | Effect of different protocols on the mitigation of exercise-induced pulmonary hemorrhage in horses when administered 24 hours before strenuous exercise. ( Bayly, W; Bergsma, G; Bergsma, J; Gold, J; Lopez, C; Sellon, D; Sides, R, 2019) |
| "Furosemide is a diuretic agent used commonly in racehorses to attenuate the bleeding associated with exercise-induced pulmonary hemorrhage (EIPH)." | 3.88 | Pharmacokinetics of furosemide administered 4 and 24 hours prior to high-speed exercise in horses. ( Arthur, RM; Jones, JH; Kass, PH; Knych, HK; Vale, A; Wilson, WD, 2018) |
| "To assess urinary aldosterone excretion (UAE) and electrolytic balance in very low-birth weight (VLBW) infants who received chronic therapy with furosemide and to compare them with those of infants who did not receive diuretic therapy." | 3.77 | Urinary aldosterone excretion and electrolytic balance in response to chronic diuretic therapy in very low-birth weight infants. ( Costa, S; Cota, F; Gallini, F; Latella, C; Maggio, L; Romagnoli, C, 2011) |
| "The objective was to quantify the effect of furosemide and carbazochrome on exercise-induced pulmonary hemorrhage (EIPH) in Standardbred horses using red blood cell count and hemoglobin concentration in bronchoalveolar lavage (BAL) fluid." | 3.75 | Effect of furosemide and furosemide-carbazochrome combination on exercise-induced pulmonary hemorrhage in Standardbred racehorses. ( Couëtil, LL; Ochoa-Acuña, HG; Perez-Moreno, CI; Pratt, SM; Raskin, RE; Russell, MA, 2009) |
| "To determine whether dorsal displacement of the soft palate (DDSP) results in pulmonary artery hypertension and leads to increases in transmural pulmonary artery pressure (TPAP); to determine whether pulmonary hypertension can be prevented by prior administration of furosemide; and to determine whether tracheostomy reduces pulmonary hypertension." | 3.70 | Effects of extrathoracic airway obstruction on intrathoracic pressure and pulmonary artery pressure in exercising horses. ( Ainsworth, DM; Ducharme, NG; Erb, HN; Erickson, BK; Hackett, RP; Soderholm, LV; Thorson, LM, 1999) |
| "The effects of furosemide on the racing times of 79 horses without exercise-induced pulmonary hemorrhage (EIPH) and 52 horses with EIPH were investigated." | 3.68 | Effects of furosemide on the racing times of Thoroughbreds. ( Holcombe, SJ; Maxson, AD; Soma, LR; Spencer, PA; Sweeney, CR; Thompson, JE, 1990) |
| "Thoroughbreds with a confirmed history of exercise-induced pulmonary hemorrhage (EIPH) were treated pre-exercise with atropine sulfate, cromolyn, ipratropium or furosemide." | 3.67 | Exercise-induced pulmonary hemorrhage in exercising Thoroughbreds: preliminary results with pre-exercise medication. ( Bucan, CA; Ray, SG; Soma, LR; Sweeney, CR, 1984) |
| "Of 61 horses with a history of exercise-induced pulmonary hemorrhage and treated with furosemide 4 hours prior to racing, 34 (55." | 3.67 | Exercise-induced pulmonary hemorrhage in thoroughbred horses: response to furosemide or hesperidin-citrus bioflavinoids. ( Soma, LR; Sweeney, CR, 1984) |
| "In 3 groups of horses with exercise-induced pulmonary hemorrhage (EIPH), comparisons of racing times and finishing positions were made between the 5 races before the horses were given furosemide and 5 races after furosemide administration." | 3.67 | Effects of furosemide on the racing times of horses with exercise-induced pulmonary hemorrhage. ( Barr-Alderfer, V; Laster, L; Oppenlander, F; Soma, LR, 1985) |
| "All furosemide-treated patients had high levels of urinary calcium (12." | 2.67 | Furosemide effect on mineral status of parenterally nourished premature neonates with chronic lung disease. ( Vileisis, RA, 1990) |
| " Chronic administration of furosemide improves both oxygenation and lung compliance." | 2.47 | Intravenous or enteral loop diuretics for preterm infants with (or developing) chronic lung disease. ( Brion, LP; Stewart, A, 2011) |
| ", washout period and delivery of furosemide to distal airways, and (2) to assess the effects of chronic administration of aerosolized furosemide on mortality, O2 dependency, ventilator dependency, length of hospital stay and long-term outcome." | 2.43 | Aerosolized diuretics for preterm infants with (or developing) chronic lung disease. ( Brion, LP; Primhak, RA; Yong, W, 2006) |
| "Furosemide was the only diuretic used in the eight studies included in this review." | 2.41 | Aerosolized diuretics for preterm infants with (or developing) chronic lung disease. ( Brion, LP; Primhak, RA; Yong, W, 2000) |
| "In preterm infants > 3 weeks of age with CLD, acute and chronic administration of furosemide improve lung compliance." | 2.41 | Intravenous or enteral loop diuretics for preterm infants with (or developing) chronic lung disease. ( Brion, LP; Primhak, RA, 2000) |
| ", washout period and delivery of furosemide to distal airways, and (2) to assess the effects of chronic administration of aerosolized furosemide on mortality, O2 dependency, ventilator dependency, length of hospital stay and long-term outcome." | 2.41 | Aerosolized diuretics for preterm infants with (or developing) chronic lung disease. ( Brion, LP; Primhak, RA; Yong, W, 2001) |
| "Sarcoidosis is a multisystem granulomatous inflammatory disorder frequently affecting the lungs, but also the liver, along with cirrhosis and portal hypertension occurring in less than 1% of the patients." | 1.51 | Finger clubbing and cirrhosis in a sarcoidosis patient. ( Bilir, M; Tetikkurt, C; Yanardag, H, 2019) |
| "Negative pressure pulmonary edema due to upper airway obstruction following extubation is a well-recognized problem." | 1.31 | Pulmonary hemorrhage in association with negative pressure edema in an intubated patient. ( Garewal, D; Sow Nam, Y, 2001) |
| "Renal calculi were seen in four patients, sonographically demonstrated as echogenic foci in the dependent portion of the collecting system, usually accompanied by acoustic shadowing." | 1.27 | Ultrasound diagnosis of renal calcification in infants on chronic furosemide therapy. ( Adelman, RD; Goetzman, BW; McGahan, JP; Myracle, MR, 1986) |
| " Similarities in their clinical courses included low birthweights, low calcium intakes, uncertain vitamin D intakes, and chronic administration of frusemide and sodium bicarbonate--all potential aetiological factors in the development of bone undermineralisation." | 1.26 | Nutritional rickets in 2 very low birthweight infants with chronic lung disease. ( Brown, DR; Chudley, AE; Holzman, IR; Oh, KS, 1980) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 20 (30.77) | 18.7374 |
| 1990's | 13 (20.00) | 18.2507 |
| 2000's | 18 (27.69) | 29.6817 |
| 2010's | 12 (18.46) | 24.3611 |
| 2020's | 2 (3.08) | 2.80 |
| Authors | Studies |
|---|---|
| Kleiner Shochat, M | 1 |
| Fudim, M | 1 |
| Kapustin, D | 1 |
| Kazatsker, M | 1 |
| Kleiner, I | 1 |
| Weinstein, JM | 1 |
| Panjrath, G | 1 |
| Rozen, G | 1 |
| Roguin, A | 1 |
| Meisel, SR | 1 |
| Cascardo, B | 1 |
| Bernardes, C | 1 |
| de Souza, GN | 1 |
| Silva, KM | 1 |
| Pires, NR | 1 |
| de Alencar, NX | 1 |
| Lessa, DAB | 1 |
| Bayly, W | 1 |
| Lopez, C | 1 |
| Sides, R | 1 |
| Bergsma, G | 1 |
| Bergsma, J | 1 |
| Gold, J | 1 |
| Sellon, D | 1 |
| Yanardag, H | 1 |
| Tetikkurt, C | 1 |
| Bilir, M | 1 |
| Pritchard, A | 1 |
| Spooner, H | 1 |
| Hoffman, R | 1 |
| Knych, HK | 2 |
| Wilson, WD | 2 |
| Vale, A | 2 |
| Kass, PH | 2 |
| Arthur, RM | 3 |
| Jones, JH | 2 |
| Sullivan, SL | 1 |
| Whittem, T | 1 |
| Morley, PS | 3 |
| Hinchcliff, KW | 4 |
| Guthrie, AJ | 1 |
| Perez-Moreno, CI | 1 |
| Couëtil, LL | 1 |
| Pratt, SM | 1 |
| Ochoa-Acuña, HG | 1 |
| Raskin, RE | 1 |
| Russell, MA | 1 |
| Costa, S | 1 |
| Cota, F | 1 |
| Romagnoli, C | 1 |
| Latella, C | 1 |
| Maggio, L | 1 |
| Gallini, F | 1 |
| Derksen, F | 1 |
| Williams, K | 1 |
| Stack, A | 1 |
| Stewart, A | 1 |
| Brion, LP | 7 |
| Guthrie, A | 1 |
| Segar, JL | 2 |
| Birks, EK | 2 |
| Shuler, KM | 1 |
| Soma, LR | 7 |
| Martin, BB | 1 |
| Marconato, L | 1 |
| Del Piero, F | 1 |
| Teleis, DC | 1 |
| Schar, D | 1 |
| Hessinger, AE | 1 |
| Uboh, CE | 3 |
| Durando, MM | 1 |
| McBride, S | 1 |
| Lundin, CS | 1 |
| Primhak, RA | 6 |
| Yong, W | 3 |
| Zawadzkas, XA | 1 |
| Sides, RH | 1 |
| Bayly, WM | 1 |
| Costa, MF | 1 |
| Thomassian, A | 1 |
| Williamson, KK | 1 |
| Davis, MS | 1 |
| Poole, DC | 2 |
| Epp, TS | 1 |
| Erickson, HH | 2 |
| Sweeney, CR | 3 |
| Bucan, CA | 1 |
| Ray, SG | 1 |
| Schwigon, CD | 1 |
| Townsend, HA | 1 |
| Waddy, AL | 1 |
| Eason, CT | 1 |
| Richards, HH | 1 |
| Hansen, NB | 1 |
| Chudley, AE | 1 |
| Brown, DR | 1 |
| Holzman, IR | 1 |
| Oh, KS | 1 |
| Pascoe, JR | 1 |
| Ferraro, GL | 1 |
| Cannon, JH | 1 |
| Wheat, JD | 1 |
| Dixon, PM | 1 |
| Stevenson, AJ | 1 |
| Weber, MP | 1 |
| Trudel, R | 1 |
| Leavitt, R | 1 |
| Woodard, D | 1 |
| Todi, F | 1 |
| Mendonca, M | 1 |
| Robillo, V | 1 |
| Young, L | 1 |
| Kacew, S | 1 |
| Tanabe, M | 1 |
| Ueda, M | 1 |
| Endo, M | 1 |
| Kitajima, M | 1 |
| Chemtob, S | 1 |
| Bell, EF | 1 |
| Ohki, Y | 1 |
| Nako, Y | 1 |
| Koizumi, T | 1 |
| Morikawa, A | 1 |
| Lester, G | 1 |
| Clark, C | 1 |
| Rice, B | 1 |
| Steible-Hartless, C | 1 |
| Vetro-Widenhouse, T | 1 |
| Hackett, RP | 1 |
| Ducharme, NG | 1 |
| Ainsworth, DM | 1 |
| Erickson, BK | 1 |
| Erb, HN | 1 |
| Soderholm, LV | 1 |
| Thorson, LM | 1 |
| Chu, KK | 1 |
| Wang, N | 1 |
| Stanley, S | 1 |
| Cohen, ND | 1 |
| Sow Nam, Y | 1 |
| Garewal, D | 1 |
| Kindig, CA | 1 |
| Geor, RJ | 1 |
| Ommundson, L | 1 |
| Fenton, G | 1 |
| Pagan, JD | 1 |
| Fuchs, D | 1 |
| Hermann, J | 1 |
| Zintl, F | 1 |
| Plenert, W | 1 |
| Alvarez Grande, J | 1 |
| Riesgo Gonzalez, I | 1 |
| Marin Iranzo, R | 1 |
| Ortega Suárez, F | 1 |
| Soler Sánchez, T | 1 |
| Gómez Huertas, E | 1 |
| Mitchell, JR | 1 |
| Jollows, DJ | 1 |
| Castile, RG | 1 |
| Kleinberg, F | 1 |
| Steinbereithner, K | 1 |
| Rudy, JA | 1 |
| Morgan, E | 1 |
| Mengeringhausen, K | 1 |
| Sams, R | 1 |
| McClay, CB | 1 |
| Weiss, DJ | 1 |
| Smith, CM | 1 |
| Gordon, B | 1 |
| Vileisis, RA | 1 |
| Maxson, AD | 1 |
| Thompson, JE | 1 |
| Holcombe, SJ | 1 |
| Spencer, PA | 1 |
| Ezzedeen, F | 1 |
| Adelman, RD | 2 |
| Ahlfors, CE | 1 |
| Myracle, MR | 1 |
| McGahan, JP | 1 |
| Goetzman, BW | 1 |
| McCann, EM | 1 |
| Lewis, K | 1 |
| Deming, DD | 1 |
| Donovan, MJ | 1 |
| Brady, JP | 1 |
| Laster, L | 1 |
| Oppenlander, F | 1 |
| Barr-Alderfer, V | 1 |
| Sahebjami, H | 1 |
| Gacad, G | 1 |
| Massaro, D | 1 |
| Hayes, MF | 1 |
| Rosenbaum, R | 1 |
| Matsumoto, T | 1 |
| Bossini, A | 1 |
| Bologna, E | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| [NCT01315223] | Phase 3 | 300 participants (Anticipated) | Interventional | 2011-03-31 | Recruiting | ||
| Single Dose of Furosemide to Improve Respiratory Distress in Moderate to Severe Bronchiolitis[NCT02469597] | Phase 2 | 46 participants (Actual) | Interventional | 2013-10-31 | Completed | ||
| A Retrospective Chart Review Evaluating the Impact of Steroid, Diuretic, and Fluid Use Practice Trends in Extreme Premature Infants at Risk for Bronchopulmonary Dysplasia (BPD) at a Single Center Neonatal Intensive Care Unit[NCT04971694] | 175 participants (Anticipated) | Observational | 2021-09-08 | Recruiting | |||
| Determining the Effect of Spironolactone on Electrolyte Supplementation in Preterm Infants With Chronic Lung Disease[NCT01721655] | Phase 2/Phase 3 | 40 participants (Anticipated) | Interventional | 2012-10-31 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
(NCT02469597)
Timeframe: Participants will be followed for the duration of hospital stay up to 1 week
| Intervention | Days (Least Squares Mean) |
|---|---|
| Single Dose of Furosemide | 3.1 |
| Placebo | 3.0 |
(NCT02469597)
Timeframe: 2 hours after medication adminstration
| Intervention | Percentage change in oxygen saturation (Least Squares Mean) |
|---|---|
| Single Dose of Furosemide | -0.14 |
| Placebo | 0.2 |
(NCT02469597)
Timeframe: 4 hours after medication adminstration
| Intervention | Percentage change in oxygen saturation (Least Squares Mean) |
|---|---|
| Single Dose of Furosemide | -0.19 |
| Placebo | 0.29 |
(NCT02469597)
Timeframe: Within 72 hours of medication administration
| Intervention | participants (Number) |
|---|---|
| Single Dose of Furosemide | 0 |
| Placebo | 0 |
(NCT02469597)
Timeframe: 2 hours after medication adminstration
| Intervention | Percentage change in respiratory rate (Least Squares Mean) |
|---|---|
| Single Dose of Furosemide | -3.7 |
| Placebo | -1.7 |
(NCT02469597)
Timeframe: 4 hours after medication adminstration
| Intervention | Percentage change in respiratory rate (Least Squares Mean) |
|---|---|
| Single Dose of Furosemide | -2.8 |
| Placebo | -5.4 |
15 reviews available for furosemide and Lung Diseases
| Article | Year |
|---|---|
A systematic review and meta-analysis of the efficacy of furosemide for exercise-induced pulmonary haemorrhage in Thoroughbred and Standardbred racehorses.
Topics: Animals; Diuretics; Furosemide; Hemorrhage; Horse Diseases; Horses; Lung Diseases; Physical Conditio | 2015 |
Exercise-induced pulmonary hemorrhage in horses: the role of pulmonary veins.
Topics: Animals; Bronchoalveolar Lavage Fluid; Capillaries; Furosemide; Hemorrhage; Horse Diseases; Horses; | 2011 |
Intravenous or enteral loop diuretics for preterm infants with (or developing) chronic lung disease.
Topics: Age Factors; Chronic Disease; Diuretics; Furosemide; Humans; Infant, Newborn; Infant, Premature; Inf | 2011 |
Intravenous or enteral loop diuretics for preterm infants with (or developing) chronic lung disease.
Topics: Age Factors; Chronic Disease; Diuretics; Furosemide; Humans; Infant, Newborn; Infant, Premature; Inf | 2011 |
Intravenous or enteral loop diuretics for preterm infants with (or developing) chronic lung disease.
Topics: Age Factors; Chronic Disease; Diuretics; Furosemide; Humans; Infant, Newborn; Infant, Premature; Inf | 2011 |
Intravenous or enteral loop diuretics for preterm infants with (or developing) chronic lung disease.
Topics: Age Factors; Chronic Disease; Diuretics; Furosemide; Humans; Infant, Newborn; Infant, Premature; Inf | 2011 |
Neonatal diuretic therapy: furosemide, thiazides, and spironolactone.
Topics: Bronchopulmonary Dysplasia; Diuretics; Ductus Arteriosus, Patent; Furosemide; Humans; Infant, Newbor | 2012 |
Neonatal diuretic therapy: furosemide, thiazides, and spironolactone.
Topics: Bronchopulmonary Dysplasia; Diuretics; Ductus Arteriosus, Patent; Furosemide; Humans; Infant, Newbor | 2012 |
Neonatal diuretic therapy: furosemide, thiazides, and spironolactone.
Topics: Bronchopulmonary Dysplasia; Diuretics; Ductus Arteriosus, Patent; Furosemide; Humans; Infant, Newbor | 2012 |
Neonatal diuretic therapy: furosemide, thiazides, and spironolactone.
Topics: Bronchopulmonary Dysplasia; Diuretics; Ductus Arteriosus, Patent; Furosemide; Humans; Infant, Newbor | 2012 |
Exercise-induced pulmonary hemorrhage.
Topics: Animals; Diuretics; Furosemide; Hemorrhage; Horse Diseases; Horses; Lung Diseases; Physical Exertion | 2003 |
Aerosolized diuretics for preterm infants with (or developing) chronic lung disease.
Topics: Aerosols; Chronic Disease; Diuretics; Furosemide; Humans; Infant, Newborn; Infant, Premature; Infant | 2006 |
Evidence-based respiratory medicine in horses.
Topics: Animals; Anti-Inflammatory Agents; Evidence-Based Medicine; Furosemide; Hemorrhage; Horse Diseases; | 2007 |
Exercise-induced pulmonary haemorrhage (EIPH): mechanistic bases and therapeutic interventions.
Topics: Aminocaproates; Animals; Diuretics; Estrogens, Conjugated (USP); Furosemide; Hemorrhage; Horse Disea | 2007 |
Review of furosemide in horse racing: its effects and regulation.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Diuresis; Diuretics; Drug Interactions; Furosemide | 1998 |
Effects of furosemide on athletic performance and exercise-induced pulmonary hemorrhage in horses.
Topics: Animals; Athletic Injuries; Diuretics; Doping in Sports; Female; Furosemide; Hemodynamics; Hemorrhag | 1999 |
Intravenous or enteral loop diuretics for preterm infants with (or developing) chronic lung disease.
Topics: Chronic Disease; Diuretics; Furosemide; Humans; Infant, Newborn; Infant, Premature; Infant, Prematur | 2000 |
Aerosolized diuretics for preterm infants with (or developing) chronic lung disease.
Topics: Aerosols; Chronic Disease; Diuretics; Furosemide; Humans; Infant, Newborn; Infant, Premature; Infant | 2000 |
Intravenous or enteral loop diuretics for preterm infants with (or developing) chronic lung disease.
Topics: Chronic Disease; Diuretics; Furosemide; Humans; Infant, Newborn; Infant, Premature; Infant, Prematur | 2000 |
Aerosolized diuretics for preterm infants with (or developing) chronic lung disease.
Topics: Aerosols; Chronic Disease; Diuretics; Furosemide; Humans; Infant, Newborn; Infant, Premature; Infant | 2001 |
Intravenous or enteral loop diuretics for preterm infants with (or developing) chronic lung disease.
Topics: Chronic Disease; Diuretics; Furosemide; Humans; Infant, Newborn; Infant, Premature; Infant, Prematur | 2002 |
9 trials available for furosemide and Lung Diseases
| Article | Year |
|---|---|
Early Impedance-Guided Intervention Improves Long-Term Outcome in Patients With Heart Failure.
Topics: Diuretics; Electric Impedance; Furosemide; Heart Failure; Humans; Lung; Lung Diseases; Outpatients; | 2021 |
Effectiveness of furosemide in attenuating exercise-induced pulmonary haemorrhage in horses when administered at 4- and 24-h prior to high-speed training.
Topics: Animals; Bronchoalveolar Lavage Fluid; Cross-Over Studies; Diuretics; Female; Furosemide; Hemorrhage | 2018 |
Efficacy of furosemide for prevention of exercise-induced pulmonary hemorrhage in Thoroughbred racehorses.
Topics: Animals; Diuretics; Female; Furosemide; Hemorrhage; Horse Diseases; Horses; Lung Diseases; Male; Phy | 2009 |
Is improved high speed performance following frusemide administration due to diuresis-induced weight loss or reduced severity of exercise-induced pulmonary haemorrhage?
Topics: Analysis of Variance; Animals; Bronchoalveolar Lavage Fluid; Cross-Over Studies; Diuretics; Exercise | 2006 |
Frusemide/amiloride combination ('Frumil') in heart failure: an open, multi-centre study in general practice.
Topics: Aged; Amiloride; Body Weight; Clinical Trials as Topic; Drug Combinations; Edema; Female; Furosemide | 1984 |
Changes in body water compartments with diuretic therapy in infants with chronic lung disease.
Topics: Body Water; Chronic Disease; Diuretics; Drug Therapy, Combination; Extracellular Space; Furosemide; | 1997 |
The effect of aerosolized furosemide in infants with chronic lung disease.
Topics: Administration, Inhalation; Aerosols; Bronchodilator Agents; Chronic Disease; Cross-Over Studies; Do | 1997 |
Furosemide effect on mineral status of parenterally nourished premature neonates with chronic lung disease.
Topics: Adenosine Monophosphate; Calcium; Chronic Disease; Furosemide; Homeostasis; Humans; Hyperparathyroid | 1990 |
Controlled trial of furosemide therapy in infants with chronic lung disease.
Topics: Chronic Disease; Clinical Trials as Topic; Double-Blind Method; Follow-Up Studies; Furosemide; Human | 1985 |
41 other studies available for furosemide and Lung Diseases
| Article | Year |
|---|---|
Diagnostic Value of Tracheal Wash Cytology for Monitoring Exercise-Induced Pulmonary Hemorrhage in Thoroughbred Racehorses.
Topics: Animals; Furosemide; Hemorrhage; Hemosiderin; Horse Diseases; Horses; Lung Diseases; Physical Condit | 2022 |
Effect of different protocols on the mitigation of exercise-induced pulmonary hemorrhage in horses when administered 24 hours before strenuous exercise.
Topics: Animals; Bronchoalveolar Lavage Fluid; Cross-Over Studies; Diuretics; Erythrocyte Count; Female; Fur | 2019 |
Finger clubbing and cirrhosis in a sarcoidosis patient.
Topics: Administration, Oral; Anti-Inflammatory Agents; Ascites; Diuretics; Female; Furosemide; Humans; Hype | 2019 |
Influence of Long-Term Furosemide Use on Bone Mineral Content, Bone Metabolism Markers, and Water Weight Loss in Horses.
Topics: Animals; Bone Density; Furosemide; Horse Diseases; Horses; Lung Diseases; Water; Weight Loss | 2019 |
Pharmacokinetics of furosemide administered 4 and 24 hours prior to high-speed exercise in horses.
Topics: Animals; Diuretics; Female; Furosemide; Hemorrhage; Horse Diseases; Horses; Lung Diseases; Male; Phy | 2018 |
Furosemide debate continues.
Topics: Animal Welfare; Animals; Diuretics; Drug Utilization; Furosemide; Hemorrhage; Horse Diseases; Horses | 2014 |
Effect of furosemide and furosemide-carbazochrome combination on exercise-induced pulmonary hemorrhage in Standardbred racehorses.
Topics: Adrenochrome; Animals; Bronchoalveolar Lavage Fluid; Cross-Over Studies; Diuretics; Drug Therapy, Co | 2009 |
Urinary aldosterone excretion and electrolytic balance in response to chronic diuretic therapy in very low-birth weight infants.
Topics: Aldosterone; Birth Weight; Chlorides; Diuretics; Furosemide; Gestational Age; Humans; Infant, Newbor | 2011 |
Use of furosemide for exercise-induced pulmonary hemorrhage in racehorses.
Topics: Animals; Diuretics; Evidence-Based Medicine; Furosemide; Hemorrhage; Horse Diseases; Horses; Lung Di | 2011 |
EIPH: postrace endoscopic evaluation of Standardbreds and Thoroughbreds.
Topics: Animals; Breeding; Diuretics; Endoscopy; Furosemide; Hemorrhage; Horse Diseases; Horses; Incidence; | 2002 |
Questions effect of furosemide on racing Thoroughbreds.
Topics: Animals; Data Interpretation, Statistical; Diuretics; Furosemide; Hemorrhage; Horses; Lung Diseases; | 1999 |
Evaluation of race distance, track surface and season of the year on exercise-induced pulmonary haemorrhage in flat racing thoroughbreds in Brazil.
Topics: Animals; Bronchoscopy; Diuretics; Female; Furosemide; Hemorrhage; Horse Diseases; Horses; Lung Disea | 2006 |
Exercise-induced pulmonary hemorrhage in exercising Thoroughbreds: preliminary results with pre-exercise medication.
Topics: Animals; Atropine; Bronchodilator Agents; Cromolyn Sodium; Furosemide; Hemorrhage; Horse Diseases; H | 1984 |
[Therapy with cefotaxime-cefotaxime/ticarcillin for bronchopulmonary infections in patients under intensive care. (author's transl)].
Topics: Aged; Bacterial Infections; Cefotaxime; Critical Care; Drug Combinations; Female; Furosemide; Humans | 1982 |
Exercise-induced pulmonary hemorrhage in thoroughbred horses: response to furosemide or hesperidin-citrus bioflavinoids.
Topics: Animals; Flavonoids; Furosemide; Hemorrhage; Hesperidin; Horse Diseases; Horses; Lung Diseases; Phys | 1984 |
Diuresis and lung function.
Topics: Diuresis; Furosemide; Humans; Infant; Lung Compliance; Lung Diseases | 1984 |
Nutritional rickets in 2 very low birthweight infants with chronic lung disease.
Topics: Bicarbonates; Bronchial Diseases; Calcium; Chronic Disease; Female; Furosemide; Humans; Infant; Infa | 1980 |
Exercise-induced pulmonary hemorrhage in racing thoroughbreds: a preliminary study.
Topics: Age Factors; Animals; Female; Furosemide; Hemorrhage; Horse Diseases; Horses; Lung Diseases; Male; P | 1981 |
Effects of furosemide on pulmonary arterial pressures of normal horses and horses affected with chronic obstructive pulmonary disease (COPD).
Topics: Animals; Blood Pressure; Furosemide; Hemorrhage; Horse Diseases; Horses; Lung Diseases; Lung Disease | 1980 |
Monitoring furosemide in racehorses participating in an EIPH program.
Topics: Animals; Chromatography, High Pressure Liquid; Drug Monitoring; Female; Furosemide; Hemorrhage; Hors | 1994 |
The effect of atrial natriuretic peptide on pulmonary acid injury in a pig model.
Topics: Animals; Atrial Natriuretic Factor; Diuretics; Furosemide; Hemodynamics; Hydrochloric Acid; Infusion | 1996 |
Effect of timing and route of administration of furosemide on pulmonary hemorrhage and pulmonary arterial pressure in exercising thoroughbred racehorses.
Topics: Animals; Bronchoalveolar Lavage; Cross-Over Studies; Diuretics; Erythrocyte Count; Female; Furosemid | 1999 |
Effects of extrathoracic airway obstruction on intrathoracic pressure and pulmonary artery pressure in exercising horses.
Topics: Airway Obstruction; Animals; Diuretics; Exercise Test; Female; Furosemide; Hemorrhage; Horse Disease | 1999 |
Statistical evaluation of the regulatory guidelines for use of furosemide in race horses.
Topics: Animals; Biometry; Diuretics; Doping in Sports; False Positive Reactions; Furosemide; Guidelines as | 2001 |
Pulmonary hemorrhage in association with negative pressure edema in an intubated patient.
Topics: Adult; Airway Obstruction; Anesthesia, General; Blood Gas Analysis; Diuretics; Furosemide; Hemorrhag | 2001 |
Role of the airways in exercise-induced pulmonary haemorrhage.
Topics: Airway Resistance; Animals; Diuretics; Furosemide; Hemorrhage; Horse Diseases; Horses; Lung Diseases | 2001 |
Effects of an external nasal strip and frusemide on pulmonary haemorrhage in Thoroughbreds following high-intensity exercise.
Topics: Animals; Body Weight; Bronchoalveolar Lavage Fluid; Carbon Dioxide; Combined Modality Therapy; Diure | 2001 |
[Basic therapy in children with leukemia and a malignant tumors. II].
Topics: Allopurinol; Anaphylaxis; Anemia; Antibiotics, Antineoplastic; Bicarbonates; Blood Transfusion; Chil | 1978 |
[Acute renal failure in drug-induced interstitial nephropathy].
Topics: Acute Kidney Injury; Aminopyrine; Anti-Bacterial Agents; Child; Dipyrone; Female; Furosemide; Humans | 1978 |
Progress in hepatology. Metabolic activation of drugs to toxic substances.
Topics: Acetaminophen; Animals; Bone Marrow Diseases; Chemical and Drug Induced Liver Injury; Chemical Pheno | 1975 |
The pathogenesis and management of massive pulmonary hemorrhage in the neonate. Case report of a normal survivor.
Topics: Asphyxia; Atropine; Blood Transfusion; Furosemide; Heart Failure; Hemorrhage; Humans; Infant, Newbor | 1976 |
[Lung in shock].
Topics: Abdomen, Acute; Adult; Dexamethasone; Furosemide; Humans; Hydrocortisone; Lung Diseases; Methylpredn | 1976 |
Plasma concentration of furosemide versus specific gravity of urine in predicting dose of administration in race horses.
Topics: Animals; Chromatography, High Pressure Liquid; Drug Administration Schedule; Furosemide; Horses; Lun | 1992 |
Evaluation of hemorheologic variables as implications for exercise-induced pulmonary hemorrhage in racing thoroughbreds.
Topics: Animals; Blood Proteins; Blood Viscosity; Erythrocyte Count; Erythrocyte Indices; Furosemide; Hemato | 1992 |
Effects of furosemide on the racing times of Thoroughbreds.
Topics: Animals; Furosemide; Hemorrhage; Horse Diseases; Horses; Lung Diseases; Physical Exertion; Sex Facto | 1990 |
Renal calcification in preterm infants: pathophysiology and long-term sequelae.
Topics: Birth Weight; Calcium; Chronic Disease; Follow-Up Studies; Furosemide; Humans; Infant, Newborn; Infa | 1988 |
Ultrasound diagnosis of renal calcification in infants on chronic furosemide therapy.
Topics: Bone and Bones; Bone Diseases; Calcinosis; Chronic Disease; Furosemide; Humans; Infant; Infant, Low | 1986 |
Effects of furosemide on the racing times of horses with exercise-induced pulmonary hemorrhage.
Topics: Animals; Furosemide; Hemorrhage; Horse Diseases; Horses; Lung Diseases; Running | 1985 |
Influence of corticosteroid on recovery from oxygen toxicity.
Topics: Animals; Ethanol; Furosemide; Ketosteroids; Lung; Lung Diseases; Male; Methylprednisolone; Organ Siz | 1974 |
Diagnosis and treatment of hemorrhagic and septic shock.
Topics: Acid-Base Equilibrium; Bacteria; Blood; Blood Volume; Dexamethasone; Furosemide; Humans; Lung Diseas | 1973 |
[Research on hyperglycemia caused by saluretics].
Topics: Diabetes Mellitus; Diuresis; Diuretics; Electrolytes; Female; Furosemide; Heart Diseases; Humans; Hy | 1967 |